Evidence map›Paper›PMID 32366307›Full record

ArticleJournal of neuroinflammation2020

The neuroregenerative effects of topical decorin on the injured mouse cornea.

Mengliang Wu, Laura E Downie, Liam M Grover, Richard J A Moakes, Saaeha Rauz, Ann Logan, Haihan Jiao, Lisa J Hill, Holly R Chinnery

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. An Epithelial Abrasion Model for Studying Corneal Wound Healing.Journal of visualized experiments : JoVE · 2021
    Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Mengliang WuDepartment of Optometry and Vision Sciences, The University of Melbourne, Parkville, Victoria, 3053, Australia.
Laura E DownieDepartment of Optometry and Vision Sciences, The University of Melbourne, Parkville, Victoria, 3053, Australia.
Liam M GroverSchool of Chemical Engineering, University of Birmingham, Birmingham, B15 2TT, UK.
Richard J A MoakesSchool of Chemical Engineering, University of Birmingham, Birmingham, B15 2TT, UK.
Saaeha RauzAcademic Unit of Ophthalmology, Institute of Inflammation and Ageing, Birmingham and Midland Eye Centre, Birmingham, UK.
Ann LoganNeuroscience and Ophthalmology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, B15 2TT, UK.
Haihan JiaoDepartment of Optometry and Vision Sciences, The University of Melbourne, Parkville, Victoria, 3053, Australia.
Lisa J HillSchool of Biomedical Sciences, Institute of Clinical Sciences, University of Birmingham, Birmingham, B15 2TT, UK.
Holly R ChinneryDepartment of Optometry and Vision Sciences, The University of Melbourne, Parkville, Victoria, 3053, Australia. holly.chinnery@unimelb.edu.au.
University of Birmingham · GBAustralian College of Optometry · AUUniversity of Melbourne · AU

Funding

Medical Research Council MR/N019016/1National Health and Medical Research Council Australia APP1126450
6 · The paper itself

Abstract

backgroundThe cornea is innervated with a rich supply of sensory nerves that play important roles in ocular surface health. Any injury or pathology of the corneal nerves increases the risk of dry eye disease and infection. This study aims to evaluate the therapeutic potential of topical decorin to improve corneal nerve regeneration in a mouse model of sterile epithelial abrasion injury.

methodsBilateral central corneal epithelial abrasions (2-mm, Alger Brush) were performed on young C57BL/6 J mice to remove the corneal sensory nerves. Decorin, or vehicle, was applied topically, three times per day for 1 week or every 2 h for 6 h. Spectral-domain optical coherence tomography was performed to measure the abrasion area and corneal thickness. Wholemount immunofluorescence staining was used to assess sensory nerve regeneration (β-tubulin III) and immune cell density (CD45, Iba1, CD11c). To investigate the specific role of dendritic cells (DCs), Cx3cr1

resultsAt 6 h after injury, topical decorin application was associated with greater intraepithelial DC recruitment but no change in re-epithelialisation or corneal thickness, compared to the vehicle control. One week after injury, sub-basal nerve plexus and superficial nerve terminal density were significantly higher in the central cornea in the decorin-treated eyes. The density of corneal stromal macrophages in the decorin-treated eyes and their contralateral eyes was significantly lower compared to saline-treated corneas. No significant improvement in corneal nerve regeneration was observed in Cx3cr1

conclusionsDecorin promotes corneal epithelial nerve regeneration after injury. The neuroregenerative effect of topical decorin was associated with a higher corneal DC density during the acute phase, and fewer macrophages at the study endpoint. The corneal neuroregenerative effects of decorin were absent in mice lacking intraepithelial DCs. Together, these findings support a role for decorin in DC-mediated neuroregeneration following corneal abrasion injury.

Indexed as

AnimalsCorneaCorneal InjuriesDecorinFemaleGelsHumansMiceMice, Inbred C57BLNerve RegenerationOphthalmic NerveRecombinant ProteinsDecorinGelsRecombinant ProteinsCorneal sensory nervesDecorinDendritic cellsImmunomodulationMacrophagesNerve regeneration

Identifiers

PMID32366307
PMCPMC7199348
OpenAlexW3021056439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.